Form 4 for EW Edwards Lifesciences
Accepted 2026-05-18 17:28:28 ET · period of report 2026-05-15 · accession 0001225208-26-005463 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-18 17:28 | 2026-05-15 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale | $82.07 | -9,968 | 22.8K | -30% | -$818.1K | |
| I | 2026-05-18 17:28 | 2026-05-15 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale | $81.82 | -8,000 | 31.0K | -21% | -$654.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | S | D | 9,968 | $82.07 | 22,798.25 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $81.975 to $82.260. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2026-05-15 | S | D | 8,000 | $81.82 | 30,969.58 | I 401(k) | — | — |